Avanir's $40M Public Offering to Aid Final Push for Zenvia.
Byline: Tiffany Turner, Staff Writer Avanir Pharmaceuticals has taken a step to push Zenvia, its late-stage investigational drug for pseudobulbar affect (PBA) further along the regulatory pipeline. The Aliso Viejo, Calif.-based company reached out to
 

More

  • China Mobile: Shanghai IPO will be small

    Description: An unhandled exception occurred during the execution of the current web request. Please review the stack trace for more information about the error and where it originated in the code. Exception Details: System.IO.FileNotFoundException:

  • Wall Street relishes Spitzer's fall from grace

    NEW YORK (Reuters) - For years, he was the scourge of the Masters of the Universe and the Sheriff of Wall Street.